President Donald Trump announced plans to impose a 200% tariff on imported pharmaceuticals and new tariffs on semiconductors, giving drugmakers up to 18 months to relocate production back to the U.S., as part of a broader push to revive domestic manufacturing in critical sectors like healthcare and technology, with the move expected to trigger global trade tensions and impact supply chains across multiple industries.
Be the first to comment